Main Sequence Ventures
Alison Deans is an accomplished business leader with extensive experience in directorship roles across various sectors. Currently serving as a Non Executive Director at Calix Limited and Deputy, Alison also holds the position of Chair and Non Executive Director at Cochlear, along with Non Executive Directorships at Ramsay Health Care and multiple organizations. As a member of the Investment Committee at Main Sequence Ventures, Alison contributes to venture capital initiatives focused on early-stage technology investments. A longstanding member of Chief Executive Women, Alison has previously held Non Executive Director positions at Westpac and IAG, and was CEO of netus. Alison holds an MBA from Stanford University and a Master of Arts in Natural Sciences from the University of Cambridge.
This person is not in any teams
This person is not in any offices
Main Sequence Ventures
2 followers
We are Australia’s deep tech investment fund tackling the world’s biggest challenges by turning today’s scientific discoveries into tomorrow’s industries. Main Sequence works closely with scientists, researchers and industry collaborators to create, fund and accelerate new companies and industries that accelerate humanity for a more prosperous future. Main Sequence was set up in 2017 to manage the CSIRO Innovation Fund, founded by the Australian Government and the national science agency to reinvest its historic contributions into the successes of the future. Over the past four years, Main Sequence has invested in 39 companies changing the way healthcare is delivered, food is produced, spaces are connected and more. These investments have led to more than 60 company collaborative projects with universities and 19 projects with CSIRO.